All In MedTech

FDA Clearance Tracker · P030011-S064

SynCardia temporary Total Artificial Heart (TAH-t) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 6, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 6, 2023

Approved

Time to decision

1,756 days

Received Sep 14, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030011-S064
Device name
SynCardia temporary Total Artificial Heart (TAH-t) System
Applicant location
Tucson, AZ
Received
Sep 14, 2018
Decided
Jul 6, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P030011

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code LOZ

FDA's approval statement

As written in FDA's record.

Approval for changes to the labeling to reflect the findings of the INTERMACS Companion post-approval Study.

Source documents

Other decisions for Syncardia Systems, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.